Skip to main content
. 2018 May 31;38(3):174–180. doi: 10.5144/0256-4947.2018.174

Table 3.

Complications and outcomes of ECMO-treated massive PE patients.

Survivor (n=6) Non-survivor (n=8) P

Complications
 Cannula site bleeding 3 (50.0) 1 (12.5) .245
 Pulmonary hemorrhage 0 (0.0) 2 (25.0) .473
 Ulcer bleeding 0 (0.0) 1 (12.5) >.999
 Compartment syn. 1 (16.7) 0 (0.0) .429
Pseudoaneurysm 1 (16.7) 0 (0.0) .429
Cannula site infection 1 (16.7) 0 (0.0) .429
Pneumonia 2 (33.3) 1 (12.5) .539
AKI 3 (50.0) 4 (50.0) >.999
MOF 0 (0.0) 4 (50.0) .085
Leg ischemia 1 (16.7) 1 (12.5) >.999
Hypoxic brain injury 2 (33.3) 3 (37.5) >.999
Neuropathy 2 (33.3) 0 (0.0) .165
Transfusion
 PRC (mL/kg) 138.4 (121.1) 81.0 (81.1) .308
 FFP (mL/kg) 32.2 (57.7) 48.2 (63.0) .635
 PC (mL/kg) 143.4 (147.1) 345.0 (451.6) .268
Ventilator duration, days 11.5 (5.5) 7.1 (7.8) .267
Hospital duration, days 41.5 (15.1) 13.9 (15.0) .005
ECMO duration, days 7.8 (3.3) 8.0 (8.1) .963

Data are expressed as mean( standard deviation) or N (%); ECMO, extracorporeal membrane oxygenation; PE, pulmonary embolism; Syn, syndrome; AKI, acute kidney injury; MOF, multiple organ failure; PRC, packed red blood cell; FFP, fresh frozen plasma; PC, platelet concentrate.